## Verdict

**8.3/10. Does not pass:** one high finding remains open, and the 9/10 threshold is not met. Rubric, 2.5 points each: prior-art attribution and bounded novelty 2.4; market evidence and citations 1.8; decision rationale and sensitivity 1.8; traceability and actionable validation plan 2.3.

The three biggest remaining problems are: (1) the RSpace price and seat terms contradict or exceed the cited primary evidence, VN-02; (2) consequential decision weights and score anchors are too subjective to support the apparent ranking precision, VN-01; and (3) the citation-audit description does not clearly distinguish the old ledger from changed claims, VN-03. The proposal-only fallback and unexecuted runtime certification are not penalized merely for being unbuilt: the plan provides a bounded procedure, pass/fail criteria, time boxes and fallback.

To reach 9 with no high findings, make every exact edit in VN-01, VN-02 and VN-03. In particular, correct the RSpace row and remove unsupported terms; add anchored ranges and conditional decisions to the four specified decision sections; and date and scope the audit description. No user study or implementation result is required to claim a plan score of 9, provided the current limits and conditional claims remain explicit.

The requested round3/research.md and round3/market.md do not exist. The immediate prior review is round3/v-novelty.md, which itself audits the named round-one research and market findings. The table covers all five immediate prior findings, including all three medium findings, and all previously partly resolved research/market findings. No missing file is treated as evidence.

## Previous findings status

| ID | Status | Evidence quote or location |
|---|---|---|

| VN-01 (round 3) | partly | round3/citations.md records 145/145 URL occurrences; 01 opening marks remaining unconfirmed claims UNVERIFIED and P2 marks exact Nature results UNVERIFIED. The audit is a dated ledger, not proof of ongoing availability; the changed RSpace row is unsupported, see VN-02. |
| VN-02 (round 3) | resolved | 01 1.1: "1.25-1.75 h minimum sequentially" and "optional 0.5 h observation ... is narrower"; 10 User study requires timing recruitment, sessions and analysis. |
| VN-03 (round 3) | partly | 10 Method calls 0.5 "a screening rule, not a robustness test" and Room layout adds a 0.80 flip example; plausible ranges and anchors remain missing for consequential decisions. See VN-01 below. |
| VN-04 (round 3) | partly | 01 1.2 marks Sakana withdrawal and voice comparison UNVERIFIED, drops unsupported scite prices, and updates RSpace and Benchling claims; the ledger supports Edison and voice abstract. Changed RSpace terms contradict the cited primary page, see VN-02. |
| VN-05 (round 3) | resolved | 10 Citation identity matching now says "Run U-C02 subset negation and mismatch cases with zero automatic passes" rather than requesting reconciliation. |
| RS-10 (carried forward) | resolved | 06 U-C10 now requires parsing into approved structured library IDs; see verified facts. |
| RS-23 (carried forward) | resolved | 01 P9: "matched voice/type error comparison is unscheduled" and "no advantage is claimed"; ACM abstract credit is recorded in the citation ledger. |
| MK-23 (carried forward) | resolved | round3/citations.md records vendor support for Edison mid-run steering and Slack, Teams and email. |
| MK-28 (carried forward) | resolved | 01 1.2 distinguishes acceptance, switching modes and Full actions mode, citing Benchling's mode and security documentation. |
| MK-29 (carried forward) | open | 01 1.2 asserts EUR4,000 / USD5,000 for 15 users and per-user rates, but the cited vendor page lists a EUR5,000 / USD6,000 minimum and no such seat terms. See VN-02. |
| MK-33 (carried forward) | resolved | 01 1.2 labels scite and Undermind current prices UNVERIFIED and removes historical exact values. |
## New findings

| ID | Severity | File and section | What is wrong | Evidence | Exact fix | Reasoning metric |
|---|---|---|---|---|---|---|

| VN-02 | high | 01 1.2, RSpace row | The revised exact managed Team price and 15-seat and per-user terms are not supported by the linked vendor page and the stated price conflicts with it. | [RSpace pricing](https://www.researchspace.com/pricing) displays academic Team EUR5,000 / USD6,000 minimum annually; no 15-user or EUR165 / USD190 terms appear in the retrieved page. The round-three ledger recorded the same minimum. | Replace the academic Team figures with EUR5,000 / USD6,000 minimum annual subscription as displayed; remove or label the seat count and additional-user tariffs UNVERIFIED until a primary source establishes them, and retain the quote caveat. | EUR4,000 versus EUR5,000 is EUR1,000 or 20% below the vendor minimum; USD5,000 versus USD6,000 is USD1,000 or 16.67% below. |

| VN-01 | medium | 10 Method, Approval mechanism, Agent count, Database and Room layout | Criteria explain why each concern matters but do not justify the particular weights or define score anchors; numeric scores and weighted ordinal differences can change the winner. The extra room example demonstrates sensitivity, not plausible bounds across high-impact choices. | Approval boundary is 45%, time 30%, visibility 25% without a tradeoff basis; Database scores 8 versus 9 for safety and has a 0.30 margin. The record explicitly labels scores subjective and tests one-point sensitivity. | In Method state that weights are illustrative preference choices and not estimated risk probabilities; for Approval mechanism, Database, Agent count and Room layout add anchored low/base/high score ranges, a plausible weight perturbation that preserves a 100% total, flip thresholds, and the decision to use if the bounds overlap. Keep hard certification gates overriding weighted totals. | Database: reducing SQLite safety by one point changes its score by 0.45, reversing its 0.30 lead by 0.15; 3 of 39 decisions are flagged within 0.5, but this is not a probability of robustness. |
| VN-03 | low | 01 opening and Related work; round3/citations.md | Audit scope wording is stale or ambiguous: the plan calls the claim audit partial and all remaining market pairs unverified, while the ledger says all occurrences were assessed; the ledger records a RSpace figure that conflicts with the revised plan. | 01 opening says "remaining market source-to-claim pairs are UNVERIFIED"; ledger says 145/145 assessed and has RSpace EUR5,000 / USD6,000, whereas the revised row says EUR4,000 / USD5,000. | In 01 opening specify the dated ledger covers the then-current 145 occurrences and changed claims require recheck; label inaccessible or unsupported details individually. Correct RSpace per VN-02; do not imply the old ledger verifies a changed claim. | 145/145 is 100% of the recorded occurrences at ledger date, not coverage of subsequent edits or proof of perpetual availability. |
## Verified facts




- [RSpace](https://www.researchspace.com/pricing) lists EUR5,000 / USD6,000 as the minimum annual academic Team subscription and separately describes self-hosting. The displayed page does not establish 15 seats or the claimed additional-user rates.
- [Benchling](https://help.benchling.com/hc/en-us/articles/48328875643533-Agent-Modes-and-Approvals) says switching from Default to Full actions requires approval; most standard actions in Full actions proceed without another approval. This supports the revised distinction.
- [LabArchives](https://www.labarchives.com/pricing) lists the academic ELN at $330/user/year, ELN plus Inventory at $360/user/year, and the free Scheduler limit of five users and five resources. The editor and integrator logged a separate vendor check of the $35 scheduler rate.
- [Nature](https://www.nature.com/articles/533452a) exposes the article title and survey description but not the numerical survey results in the preview. The current plan properly marks those results UNVERIFIED.
- The citation ledger is the supplied baseline for unchanged links, not a newly repeated audit. It records 145/145 occurrences assessed, including one inaccessible source and four partial rows across all plan files. Changed scoped claims were rechecked using four primary-page opens; inaccessible exact details remain qualified.
- An independent script checked all 39 decision sections, 78 weighted formulas, corresponding criterion weights and option scores, and 39 margins: zero arithmetic mismatches. Weights sum to 100% in every section. One-point sensitivity changes of 0.45, 0.40 and 0.35, and the room-layout two-point change of 0.80, are correct.
- README scenario totals are correct: 24 + 16.25 + 13.75 + 14 = 68; 24 + 17.5 + 16.25 + 15 = 72.75; 27 + 20 + 18.75 + 17 = 82.75. They are conditional editorial judgments, not earned scores.
- Other displayed calculations checked: 99/176 = 56.25%; 84 - 62 = 22 percentage points; 155 x 0.21 = 32.55, approximately 33; 10 x 2 x 30 seconds = 10 minutes; 10 x $35 = $350; 12 x $50 = $600; 12 x 2 x $25 = $600; one fewer of five agents = 20%; 25 + 35 + 25 + 20 + 15 = 120 minutes; 23:59 minus 19:00 = 4 hours 59 minutes. The full pilot's sequential bounds add to 1.25-1.75 hours.
- U-C10 now says "Resolve DOI or author-year references to unique verified library IDs" and sends ambiguous, unmatched or unsupported references to review, while keeping claim support separate.

